Russia has approved a controversial Covid-19 vaccine for widespread use after less than two months of human testing, including a dose administered to one of Vladimir Putin’s daughters.
Kirill Dmitriev, the head of the country’s RDIF sovereign wealth fund, said the vaccine would be marketed abroad under the brand name Sputnik V with international agreements to produce 500m doses and requests for 1bn doses from 20 countries.
The vaccine’s name evokes the world’s first satellite to be launched into orbit, Sputnik, during the cold war space race, which was also seen as a competition for international prestige.
Get your custom MOON reading
